Toggle Side Panel
News + Resources
Market Trends
Downloads & Resources
CDMO News
CRO News
Biotech Profiles
Podcast
Directory
Events
CDMO Live Europe
CDMO Live Americas
ExM Leaders
More options
Sign in
Sign up
Search for:
News + Resources
Market Trends
Downloads & Resources
CDMO News
CRO News
Biotech Profiles
Podcast
Directory
Events
CDMO Live Europe
CDMO Live Americas
ExM Leaders
Search for:
Close search
Policy Briefings
Trump Gives Generic Drugmakers Two Years to Reshore Before Tariffs Hit
Congress Proposes Federal Oversight for US-China Drug Licensing Deals
FDA Shakeup Continues: Høeg Fired, Davis Named Acting CDER Head
Trump Confirms Makary Exit; Diamantas Named Acting Chief
Regeneron Closes MFN Deal; Offers Gene Therapy Free
US Pharma Tariffs: 100% Headline Rate, Far Lower Real-World Impact
The European Biotech Act, Explained
Multistate Lawsuit Targets CDC Childhood Vaccine Rollback
Trump’s Tariffs Are Off — Or Are They? What Pharma Does Next
FDA and EMA Issue Joint AI Principles for Drug Development
EU Critical Medicines Act: What Manufacturing Leaders Must Prepare For
TrumpRx Launches: Will Direct-to-Consumer Platform Actually Lower Drug Costs?
J&J Strikes Drug Pricing Deal with Trump Administration
Nine Drugmakers Sign Trump MFN Deals in Single Day, Pledge $150B in US Manufacturing
US–UK Deal Sets Zero Tariffs, Raises UK Drug Value Thresholds
Trump Administration Launches Review of Global Drug Pricing Practises
AstraZeneca Signs Trump’s Second MFN Drug Pricing Deal
Trump Exempts Generic Drugs from Pharmaceutical Tariffs, Boosting Indian Pharma Stocks
UK Considers Raising NHS Drug Prices to Avoid US Tariffs
Trump Delays 100% Pharma Tariffs to Negotiate Pricing Deals
TrumpRx: Pfizer Signs First Deal for US Drug Platform
« Previous
Page
1
Page
2
Next »
Evinova Partners with Merck KGaA to Advance AI-Driven Clinical Development
Lifecore Biomedical Signs Three New Customer Agreements Across Development Programs
Cellipont Bioservices Completes 100 GMP Batch Releases at Texas Facility
AGC Biologics Secures Multi-Year Yokohama Manufacturing Contract Worth Hundreds of Millions
ProBioGen Partners with VarmX to Develop Therapeutic Factor X Candidate
Celonic AG and Leukocare AG Partner to Support Complex Biologics Development
Kyverna Therapeutics Signs Manufacturing Agreement with ElevateBio for miv-cel
AsymBio Breaks Ground on New Shanghai Biologics R&D Building
Pace Life Sciences Completes FDA Inspection of North Carolina Small Molecule Center
Asymchem’s Carbapenem API Facility Passes First USFDA Pre-Approval Inspection
Laurus Labs Posts 67% CDMO Growth Driven by Small Molecule Demand
Polpharma API Selected by Celon Pharma for ADC Payload-Linker Manufacturing
Bachem to Invest More Than CHF 500 Million(US$620M) in Sisslerfeld Manufacturing Site
Phlow Welcomes US$15.97 Million EDA Investment for Domestic Medicine Commercialization
Bora Pharmaceuticals Signs Manufacturing Agreement for Onconic’s JAQBO U.S. Phase 3 Trial
FAMAR Appoints Bruce Vielle as Chief Executive Officer
Hikal Commissions cGMP Pilot Plant at Pune R&T Campus
Samsung Biologics Reports KRW 1,321 Billion(US$944M) Q2 2026 Revenue
« Previous
Page
1
Page
2
Page
3
Page
4
Page
5
Next »
European CDMO Landscape 2025:
Download the latest edition